Hanné Andersen
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research 14
- COVID-19 Clinical Research Studies 7
- Immunology top 5%
- Immunotherapy and Immune Responses 9
- Immune Cell Function and Interaction 8
- Virology top 5%
- Epidemiology top 2%
- Influenza Virus Research Studies 10
- Respiratory viral infections research 8
- Herpesvirus Infections and Treatments 6
-
- Animal Virus Infections Studies 6
Hanné Andersen
47 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Infectious Diseases 1.3k
- Immunology 744
- Virology 163
- Epidemiology 1.1k
- Public Health, Environmental and Occupational Health 461
Countries citing papers authored by Hanné Andersen
This map shows the geographic impact of Hanné Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanné Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanné Andersen more than expected).
Fields of papers citing papers by Hanné Andersen
This network shows the impact of papers produced by Hanné Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanné Andersen. The network helps show where Hanné Andersen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hanné Andersen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 6 | |
| 6 | 2022 | 1 | |
| 7 | 2021 | 27 | |
| 8 | 2021 | 12 | |
| 9 | SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolutionbreakdown → | 2021 | 230 |
| 10 | 2021 | 31 | |
| 11 | 2020 | 2 | |
| 12 | 2018 | 33 | |
| 13 | 2017 | 13 | |
| 14 | 2016 | 28 | |
| 15 | 2010 | 277 | |
| 16 | 2010 | 367 | |
| 17 | 2010 | 75 | |
| 18 | 2007 | 18 | |
| 19 | 2004 | 10 | |
| 20 | 2000 | 11 |
About Hanné Andersen
Hanné Andersen is a scholar working on Infectious Diseases, Immunology and Virology, having authored 49 papers that have together received 2.5k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (14 papers), Influenza Virus Research Studies (10 papers), Immunotherapy and Immune Responses (9 papers), Respiratory viral infections research (8 papers), Immune Cell Function and Interaction (8 papers), COVID-19 Clinical Research Studies (7 papers), Animal Virus Infections Studies (6 papers) and Herpesvirus Infections and Treatments (6 papers). The work is most often cited by research in Infectious Diseases (1.3k citations), Immunology (744 citations) and Virology (163 citations). Hanné Andersen has collaborated with scholars based in United States, Denmark and Sweden. Frequent co-authors include Srinivas S. Rao, Gary J. Nabel, Mark G. Lewis, Chih‐Jen Wei, Wing-Pui Kong, Jeffrey C. Boyington, Patrick M. McTamney, Stephen Higgs, Terrence M. Tumpey and Zhiyong Yang. Their work appears in journals such as Frontiers in Immunology, Cellular Immunology, Journal of Virology, PLoS ONE and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.